Compounds > methoxyhydroxyphenylglycol
Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Autonomic Failure, Progressive

methoxyhydroxyphenylglycol has been researched along with Autonomic Failure, Progressive in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, RP; Diedrich, A; Robertson, D1
Brentzel, S; Eisenhofer, G; Goldstein, DS; Holmes, C; Sharabi, Y1
Ebert, MH; Kopin, IJ; Oddershede, IR; Oliver, JA; Polinsky, RJ1
Hamamoto, M; Miyazaki, T; Otsubo, K; Terashi, A; Ueda, M1
Blandini, F; Bono, G; Martignoni, E; Nappi, G; Pacchetti, C; Petraglia, F1
Lindvall, B; Olsson, JE1

Other Studies

6 other study(ies) available for methoxyhydroxyphenylglycol and Autonomic Failure, Progressive

ArticleYear
Autonomic control after blockade of the norepinephrine transporter: a model of orthostatic intolerance.
    Journal of applied physiology (Bethesda, Md. : 1985), 2002, Volume: 93, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Animals; Baroreflex; Blood Pressure; Body Weight; Desipramine; Female; Heart Rate; Methoxyhydroxyphenylglycol; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Shy-Drager Syndrome; Sympathetic Nervous System; Symporters; Tachycardia

2002
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
    Neurology, 2003, Apr-22, Volume: 60, Issue:8

    Topics: Adrenal Medulla; Aged; Autonomic Nervous System Diseases; Catechols; Epinephrine; Female; Heart Conduction System; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Parkinson Disease; Shy-Drager Syndrome; Supine Position; Sympathetic Nervous System

2003
Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:3

    Topics: Humans; Hypotension, Orthostatic; Methoxyhydroxyphenylglycol; Middle Aged; Nervous System Diseases; Norepinephrine; Normetanephrine; Shy-Drager Syndrome; Sympathetic Nervous System; Vanilmandelic Acid

1983
[Monoamine imbalance of the central nervous system in a case of Shy-Drager syndrome with recurrent attacks of a neuroleptic malignant syndrome].
    Rinsho shinkeigaku = Clinical neurology, 1996, Volume: 36, Issue:5

    Topics: Aged; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Neuroleptic Malignant Syndrome; Shy-Drager Syndrome

1996
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.
    Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:3

    Topics: Adult; Aged; Alzheimer Disease; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Norepinephrine; Parkinson Disease; Peripheral Nervous System Diseases; Severity of Illness Index; Shy-Drager Syndrome; Spinal Cord Diseases

1992
Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Advances in neurology, 1990, Volume: 53

    Topics: Dystonia Musculorum Deformans; Enkephalin, Methionine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Shy-Drager Syndrome; Somatostatin

1990